JW Pharmaceutical Corporation (KRX:001060)
23,650
+800 (3.50%)
At close: Oct 27, 2025
JW Pharmaceutical Market Cap
JW Pharmaceutical has a market cap or net worth of 542.47 billion as of October 27, 2025. Its market cap has decreased by -17.90% in one year.
Market Cap
542.47B
Enterprise Value
560.68B
Revenue
742.85B
Ranking
n/a
PE Ratio
11.20
Stock Price
23,650.00
Market Cap Chart
Since April 29, 2003, JW Pharmaceutical's market cap has increased from 84.02B to 542.47B, an increase of 545.63%. That is a compound annual growth rate of 8.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 542.47B | -3.42% |
| Dec 30, 2024 | 561.70B | -32.21% |
| Dec 28, 2023 | 828.52B | 97.41% |
| Dec 29, 2022 | 419.69B | -17.00% |
| Dec 30, 2021 | 505.68B | -32.85% |
| Dec 30, 2020 | 753.06B | 22.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 83.84T |
| Celltrion | 38.09T |
| ALTEOGEN | 23.85T |
| Yuhan | 8.54T |
| SK Biopharmaceuticals | 8.34T |
| Peptron | 6.00T |
| HLB Co., Ltd. | 5.98T |
| PharmaResearch | 5.69T |